Search Results - "von Muhlen, C A"

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial by Rigby, W., Tony, H.-P., Oelke, K., Combe, B., Laster, A., von Muhlen, C. A., Fisheleva, E., Martin, C., Travers, H., Dummer, W.

“…Objective To evaluate the efficacy and safety of treatment with ocrelizumab plus methotrexate (MTX) in patients with active rheumatoid arthritis (RA) and an…”
Get full text

Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015 by Chan, E K L, Damoiseaux, J, de Melo Cruvinel, W, Carballo, O G, Conrad, K, Francescantonio, P L C, Fritzler, M J, Garcia-De La Torre, I, Herold, M, Mimori, T, Satoh, M, von Mühlen, C A, Andrade, L E C

“…The second meeting for the International Consensus on Antinuclear antibody (ANA) Pattern (ICAP) was held on 22 September 2015, one day prior to the opening of…”
Get full text

Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection by KESSENBROCK, K, FRITZLER, M. J, GROVES, M, EISSFELLER, P, VON MÜHLEN, C. A, HÖPFL, P, MAHLER, M

“…Autoantibodies to the three ribosomal P proteins (Rib-P) are specifically found in 10% to 40% of systemic lupus erythematosus (SLE) patients. Most anti-Rib-P…”
Get full text

IgA antibodies to beta2-glycoprotein I and carotid disease by Recuero, M L, Silva, J B, Norman, G L, von Mühlen, C A, Staub, H L

Get full text

Anti-Golgi antibodies in adult Still's disease by Staub, H L, Souza, F, Chan, E K L, von Mühlen, C A

Get full text

IgA antibodies to beta2-glycoprotein I and atherosclerosis by Staub, H.L., Franck, M., Ranzolin, A., Norman, G.L., Iverson, G.M., von Mühlen, C.A.

Get full text

Immunoglobulin allotype Gm(1,2;21) in ankylosing spondylitis with peripheral arthritis by Mierau, R, von Mühlen, C A, Zarnowski, H, Genth, E, Hartl, P W

“…Frequencies of immunoglobulin G (Gm) allotypes were determined in 240 patients with ankylosing spondylitis (AS). The uncommon phenotype Gm(1,2;21) was…”
Get full text

Autoantibodies to the nucleolar organizer antigen NOR-90 in children with systemic rheumatic diseases by Fritzler, M J, von Muhlen, C A, Toffoli, S M, Staub, H L, Laxer, R M

“…To determine the frequency of autoantibodies directed against the nucleolar organizer antigen NOR-90 [human upstream binding factor (hUBF)] in pediatric…”
Get more information

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database by Tyndall, Anthony J, Bannert, Bettina, Vonk, Madelon, Airò, Paolo, Cozzi, Franco, Carreira, Patricia E, Bancel, Dominique Farge, Allanore, Yannick, Müller-Ladner, Ulf, Distler, Oliver, Iannone, Florenzo, Pellerito, Raffaele, Pileckyte, Margarita, Miniati, Irene, Ananieva, Lidia, Gurman, Alexandra Balbir, Damjanov, Nemanja, Mueller, Adelheid, Valentini, Gabriele, Riemekasten, Gabriela, Tikly, Mohammed, Hummers, Laura, Henriques, Maria J S, Caramaschi, Paola, Scheja, Agneta, Rozman, Blaz, Ton, Evelien, Kumánovics, Gábor, Coleiro, Bernard, Feierl, Eva, Szucs, Gabriella, Von Mühlen, Carlos Alberto, Riccieri, Valeria, Novak, Srdan, Chizzolini, Carlo, Kotulska, Anna, Denton, Christopher, Coelho, Paulo C, Kötter, Ina, Simsek, Ismail, de la Pena Lefebvre, Paloma García, Hachulla, Eric, Seibold, James R, Rednic, Simona, Stork, Jirí, Morovic-Vergles, Jadranka, Walker, Ulrich A

“…To determine the causes and predictors of mortality in systemic sclerosis (SSc). Patients with SSc (n=5860) fulfilling the American College of Rheumatology…”
Get more information

Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study by Elhai, Muriel, Meunier, Marine, Matucci-Cerinic, Marco, Maurer, Britta, Riemekasten, Gabriela, Leturcq, Tifenn, Pellerito, Raffaele, Von Mühlen, Carlos Alberto, Vacca, Alessandra, Airo, Paolo, Bartoli, Francesca, Fiori, Ginevra, Bokarewa, Maria, Riccieri, Valeria, Becker, Mike, Avouac, Jérôme, Müller-Ladner, Ulf, Distler, Oliver, Allanore, Yannick

“…To evaluate the safety and effectiveness of tocilizumab and abatacept in systemic sclerosis (SSc)-polyarthritis or SSc-myopathy. 20 patients with SSc with…”
Get more information

Autoantibodies in the diagnosis of systemic rheumatic diseases by VON MÜHLEN, C. A, TAN, E. M

“…Distinct profiles of autoantibodies directed to intracellular antigens can be detected in the systemic connective tissue diseases. They aid in establishing the…”
Get full text

Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF by Silveira, I G, Burlingame, R W, von Mühlen, C A, Bender, A L, Staub, H L

“…To compare the diagnostic powers of rheumatoid factor (RF) and anti-cyclic citrullinated peptide (CCP) in a population selected for its high statistical…”
Get full text

Non‐muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus‐associated chronic liver diseases by MÜHLEN, C. A., CHAN, E. K. L., PEEBLES, C. L., IMAI, H., KIYOSAWA, K., TAN, E. M.

“…SUMMARY Three patients with hepatitis C virus (HCV)‐related chronic liver disease were shown to have autoantibodies strongly reacting with cytoskeletal fibres…”
Get full text

Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis by Saketkoo, Lesley Ann, Valenzuela, Antonia, Kim, Susan, McCann, Liza J, Lood, Christian, Wahezi, Dawn M, Werth, Victoria P, Yi, Belina, Alexanderson, Helene, Maillard, Susan, Pilkington, Clarissa, Fligelstone, Kim, Limbach, Barbara, Orandi, Amir B, Regardt, Malin, Russell, Anne-Marie, Davuluri, Srijana, deGroot, Ingrid, Ernste, Floranne, Paik, Julie J, von Muhlen, Carlos A, Dimachkie, Mazen M, Machado, Pedro M, Naddaf, Elie, Shafranski, Barbara M, Gupta, Latika, Zulian, Francesco, Chung, Lorinda

Get full text

Beta2-glycoprotein I IgA antibodies and ischaemic stroke by Staub, H L, von Muhlen, C A, Norman, G L

Get full text

[beta]2-Glycoprotein I IgA antibodies and ischaemic stroke by Staub, H L, von Muhlen, C A, Norman, G L

Get full text

β 2-Glycoprotein I IgA antibodies and ischaemic stroke by Staub, H. L., von Muhlen, C. A., Norman, G. L.

Get full text

β2-Glycoprotein I IgA antibodies and ischaemic stroke by Staub, H. L., von Muhlen, C. A., Norman, G. L.

Get full text

International Multicenter Evaluation of Autoantibodies to Ribosomal P Proteins by Mahler, Michael, Kessenbrock, Kai, Szmyrka, Magdalena, Takasaki, Yoshinari, Garcia-De La Torre, Ignacio, Shoenfeld, Yehuda, Hiepe, Falk, Shun-le, Chen, von Mühlen, Carlos A, Locht, Henning, Höpfl, Peter, Wiik, Allan, Reeves, Westley, Fritzler, Marvin J

“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Motor activity of the gallbladder in systemic sclerosis by Lopes, Maria Helena I, Ludwig, Eduardo, do Amaral, Beatriz B, Francisconi, Carlos F, von Mühlen, Carlos A

“…We sought to measure gallbladder emptying in scleroderma patients, when stimulated by exogenous cholecystokinin. Twenty-eight consecutive scleroderma patients…”
Get full text